Pilar Martinez Martinez (M.P.)

Arets, B., Peng, S., Bracke, L., De Winter, K., Delaere, J., Driege, Y., Delahaye, T., Moshir, M., Van de Walle, I., Ulrichts, P., Mane-Damas, M., Losen, M., & Martinez-Martinez, P. (2026). Anti-C2-mediated complement inhibition prevents disease in a rat passive transfer model of myasthenia gravis. Journal of Translational Autoimmunity, 13, Article 100388. https://doi.org/10.1016/j.jtauto.2026.100388

Du, P., Mane-Damas, M., Verhamme, F. M., Moshir, M., Ulrichts, P., Machiels, B., Losen, M., & Martinez-Martinez, P. (2026). Optimization of the Cell-Based Assay Methodology to Study Degradation of Acetylcholine Receptors (Antigenic Modulation) by Antibodies From Myasthenia Gravis Patients. Muscle & Nerve, 74(S1), S150-S158. https://doi.org/10.1002/mus.70319

Crivelli, S. M., Quadri, Z., Van Kruining, D., Martinez-Martinez, P., Bieberich, E., & Chatton, J.-Y. (2026). Editorial: The role of glial cells in the pathophysiology and treatment of Alzheimer's disease. Frontiers in Neuroscience, 19, Article 1749170. https://doi.org/10.3389/fnins.2025.1749170

Arets, B., Mané-Damas, M., Schöttler, A. K., Sikorski, P. M., Kusner, L. L., Kaminski, H. J., Losen, M., & Martinez-Martinez, P. (2025). Refinement of the rat acetylcholine receptor-specific passive transfer myasthenia gravis model using subcutaneous injections: an update to the guidelines. Scientific Reports, 15(1), Article 33062. https://doi.org/10.1038/s41598-025-15187-2

Mané-Damas, M., Schöttler, A. K., Marcuse, F., Molenaar, P., Mohile, T., Hoeijmakers, J., Hochstenbag, M., Damoiseaux, J., Maessen, J., Abdul-Hamid, M., Zur Hausen, A., de Baets, M., Losen, M., & Martinez-Martinez, P. (2025). Myasthenia gravis with antibodies against the AChR, current knowledge on pathophysiology and an update on treatment strategies with special focus on targeting plasma cells. Autoimmunity Reviews, 24(10), Article 103875. https://doi.org/10.1016/j.autrev.2025.103875

Mane-Damas, M., Schottler, A. K., Mohile, T., Arets, B., Tuzun, E., Losen, M., & Martinez-Martinez, P. (2025). Hock immunization, a refined alternative for developing experimental autoimmune myasthenia gravis (EAMG) in mice. Scientific Reports, 15(1), Article 31893. https://doi.org/10.1038/s41598-025-12446-0

van de Burgt, N. A., Kulsvehagen, L., Mane-Damas, M., Lutz, L., Lecourt, A.-C., Monserrat, C., Vinke, A. M., Kucukali, C. I., Zong, S., Hoffmann, C., Gonzalez-Vioque, E., Arango, C., Leibold, N. K., Losen, M., Molenaar, P. C., Tuzun, E., van Beveren, N. J. M., Mane, A., Rouhl, R. P. W., ... Genetic Risk Outcome Psychosis GROUP Investigators (2025). Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms. Frontiers in Neurology, 16, Article 1593042. https://doi.org/10.3389/fneur.2025.1593042

van Kruining, D., Losen, M., Dehairs, J., Swinnen, J. V., Waelkens, E., Honing, M., & Martinez-Martinez, P. (2025). Early plasma ceramide and sphingomyelin levels reflect APOE genotype but not familial Alzheimer's disease gene mutations in female 5xFAD mice, with brain-region specific sphingolipid alterations. Neurobiology of Disease, 210, Article 106923. https://doi.org/10.1016/j.nbd.2025.106923